Late October 2025 saw the REVESE team from Barcelona's ISGlobal back in action undertaking the second country visit for the Discrete Choice Experiment pilot!

These country visits are a key component of the project's objective to explore the transferability of the proposed intervention programmes outside Europe and to better understand the contextual factors influencing the uptake of antimicrobial resistance (AMR) prevention and clinical management strategies in diverse global settings.

The team, including Friederike Roeder (predoctoral researcher) and Elisa Sicuri (lead researcher task 6.6), traveled to Manhiça in Maputo Province, Mozambique to meet the team from the Manhiça Health Research Centre (CISM).

They met the local teams to provide training on data collection and the DCE pilot. The team established and strengthened collaborations and discussed how the REVERSE project's findings could directly inform local policy an patient care in Mozambique.

The Manhiça Health Research Centre is a Mozambician non-profit organisation that carriers out biomedical research in priority areas aimed at improving the health of the most vulnerable populations. The centre was founded in 1996 with the support of the Hospital Clínic de Barcelona under the leadership of Dr. Pedro Alonso.

In recent years, the work of the CISM has included the creation of a key research agenda, training researchers and technical staff, and supporting healthcare in the district of Manhiça. CISM is acknowledged as one of the leading health research centres in Africa.

Mozambique is a sub-Saharan African country with a population of over 30 million. The healthcare system is government-funded providing healthcare services to most of the population through the Ministry of Health, which manages public hospitals and healthcare centres. Mozambique's strategic plan for the health sector outlines objectives to promote ongoing and sustained improvement of health assistance while addressing challenges associated with demographic discrepancies and epidemiological changes. 

Towards a Global Impact on AMR

The REVERSE project's overarching goal is to develop recommendations and implementation strategies for AMR prevention and clinical management that are effective in high AMR prevalence settings within Europe, and critically, to ensure their transferability to selected countries outside Europe. The findings from these pilots in Mozambique and Guyana will be instrumental in achieving this objective, with the insight gathered used to extrapolate the study results and recommendations to other settings and will complement the findings of WP5 - Implementation.